182 related articles for article (PubMed ID: 14708714)
1. Hide-and-seek in the brain: a role for HLA-G mediating immune privilege for glioma cells.
Wiendl H; Mitsdoerffer M; Weller M
Semin Cancer Biol; 2003 Oct; 13(5):343-51. PubMed ID: 14708714
[TBL] [Abstract][Full Text] [Related]
2. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.
Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Bornemann A; Meyermann R; Weiss EH; Melms A; Weller M
J Immunol; 2002 May; 168(9):4772-80. PubMed ID: 11971028
[TBL] [Abstract][Full Text] [Related]
3. HLA-G in the nervous system.
Wiendl H
Hum Immunol; 2007 Apr; 68(4):286-93. PubMed ID: 17400065
[TBL] [Abstract][Full Text] [Related]
4. Janus head: the dual role of HLA-G in CNS immunity.
Huang YH; Airas L; Schwab N; Wiendl H
Cell Mol Life Sci; 2011 Feb; 68(3):407-16. PubMed ID: 21086150
[TBL] [Abstract][Full Text] [Related]
5. [HLA-G: immune tolerance in normal and pathological physiology].
Le Discorde M; Moreau P; Rouas-Freiss N; Carosella E
Pathol Biol (Paris); 2002 Feb; 50(1):45-51. PubMed ID: 11873630
[TBL] [Abstract][Full Text] [Related]
6. The role of HLA-G for protection of human renal cell-carcinoma cells from immune-mediated lysis: implications for immunotherapies.
Bukur J; Seliger B
Semin Cancer Biol; 2003 Oct; 13(5):353-9. PubMed ID: 14708715
[TBL] [Abstract][Full Text] [Related]
7. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
8. HLA-G and lymphoproliferative disorders.
Amiot L; Le Friec G; Sebti Y; Drénou B; Pangault C; Guilloux V; Leleu X; Bernard M; Facon T; Fauchet R
Semin Cancer Biol; 2003 Oct; 13(5):379-85. PubMed ID: 14708718
[TBL] [Abstract][Full Text] [Related]
9. HLA-G in cancer: a way to turn off the immune system.
Rouas-Freiss N; Moreau P; Menier C; Carosella ED
Semin Cancer Biol; 2003 Oct; 13(5):325-36. PubMed ID: 14708712
[TBL] [Abstract][Full Text] [Related]
10. Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
Wischhusen J; Waschbisch A; Wiendl H
Semin Cancer Biol; 2007 Dec; 17(6):459-68. PubMed ID: 17768067
[TBL] [Abstract][Full Text] [Related]
11. Is antigen presentation the primary function of HLA-G?
Le Bouteiller P; Solier C
Microbes Infect; 2001 Apr; 3(4):323-32. PubMed ID: 11334750
[TBL] [Abstract][Full Text] [Related]
12. Functions of HLA-G in the immune system.
Favier B; LeMaoult J; Carosella ED
Tissue Antigens; 2007 Apr; 69 Suppl 1():150-2. PubMed ID: 17445191
[TBL] [Abstract][Full Text] [Related]
13. HLA-G in melanoma: A new strategy to escape from immunosurveillance?
Ugurel S; Reinhold U; Tilgen W
Onkologie; 2002 Apr; 25(2):129-34. PubMed ID: 12006763
[TBL] [Abstract][Full Text] [Related]
14. Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis.
Rouas-Freiss N; Bruel S; Menier C; Marcou C; Moreau P; Carosella ED
Int J Cancer; 2005 Oct; 117(1):114-22. PubMed ID: 15880415
[TBL] [Abstract][Full Text] [Related]
15. The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy.
Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Weiss EH; Dichgans J; Lochmuller H; Hohlfeld R; Melms A; Weller M
Brain; 2003 Jan; 126(Pt 1):176-85. PubMed ID: 12477705
[TBL] [Abstract][Full Text] [Related]
16. The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.
Algarra I; García-Lora A; Cabrera T; Ruiz-Cabello F; Garrido F
Cancer Immunol Immunother; 2004 Oct; 53(10):904-10. PubMed ID: 15069585
[TBL] [Abstract][Full Text] [Related]
17. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
18. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
Rouas-Freiss N; Moreau P; Ferrone S; Carosella ED
Cancer Res; 2005 Nov; 65(22):10139-44. PubMed ID: 16287995
[TBL] [Abstract][Full Text] [Related]
19. The role of HLA-G in human pregnancy.
Hunt JS; Langat DK; McIntire RH; Morales PJ
Reprod Biol Endocrinol; 2006; 4 Suppl 1(Suppl 1):S10. PubMed ID: 17118165
[TBL] [Abstract][Full Text] [Related]
20. HLA-G in the human placenta: expression and potential functions.
Le Bouteiller P
Biochem Soc Trans; 2000 Feb; 28(2):208-12. PubMed ID: 10816129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
